Sign in

CIK 0001819576

  • Non-accelerated filer

Liquidia Corp

Sign in to watch
Ticker
LQDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
851710962
Phone
+1 919-328-4400
Business address
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC, 27560
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Planned sale Chief Commercial Officer sold 651 shares at $8.08 ($5,260)
  7. 4 Exercise or conversion General Counsel acquired 2,344 shares (option exercise)
  8. 4 Planned sale Chief Operations Officer sold 597 shares at $8.08 ($4,824)
  9. 4 Exercise or conversion Chief Financial Officer acquired 2,344 shares (option exercise)
  10. 4/A Open-market sale Chief Commercial Officer sold 2,171 shares at $7.56 ($16,405)
  11. 4/A Grant or award Chief Commercial Officer acquired 2,160 shares (grant or award)
  12. 4/A Grant or award Chief Executive Officer acquired 993 shares (grant or award)
  13. 4/A Grant or award Chief Financial Officer acquired 1,927 shares (grant or award)
  14. 4/A Grant or award Chief Operations Officer acquired 1,918 shares (grant or award)
  15. 4/A Grant or award General Counsel acquired 2,166 shares (grant or award)
  16. 4 Open-market sale Chief Operations Officer sold 2,033 shares at $7.56 ($15,362)
  17. 4 Exercise or conversion Chief Financial Officer acquired 9,375 shares (option exercise)
  18. 4 Open-market sale Chief Commercial Officer sold 2,171 shares at $7.56 ($16,405)
  19. 4 Exercise or conversion General Counsel acquired 9,375 shares (option exercise)
  20. 4 Grant or award Chief Operations Officer acquired 83,333 shares (grant or award)

Page 15 of 21 · 414 filings